Granules India Company Description

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India and internationally.

It offers paracetamol, metformin, guaifenesin, and methocarbamol, as well as prescription and over-the-counter products.

The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions.

In addition, it provides development and manufacturing solutions for peptides, peptide fragments, and amino acid derivatives.

The company offers its products in various therapeutic categories, including antiretroviral, anti-depressant, antihistamine, anti-diabetic, anti-cancer, multiple sclerosis, anti-thrombocytopenia, anti-ulcer, anti-convulsant, mucolytic/expectorant, anti-hypertensive, muscle relaxant, NSAIDs, anti-fibrotic, and anti-microbial, as well as anti-arrhythmic, CNS stimulant, anti-diarrheal, antihypertensive, uterine stimulant, chelating agent, mineral supplements, CNS depressant, PDE inhibitor, antispasmodic, and anti-viral.

Granules India Limited was incorporated in 1984 and is headquartered in Hyderabad, India.

Granules India Limited

Country	India
Founded	1984
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	4,066
CEO	Krishna Chigurupati

Contact Details

Address: Granules Tower Hyderabad, 500084 India
Phone	91 40 6904 3500
Website	granulesindia.com

Stock Details

Ticker Symbol	GRANULES
Exchange	National Stock Exchange of India
Fiscal Year	April - March
Reporting Currency	INR
ISIN Number	INE101D01020
SIC Code	2834

Key Executives

Name	Position
Dr. Krishna Prasad Chigurupati B.Sc.	Chairman and MD
Priyanka Chigurupati	Head of Marketing and Executive Director
Harsha Chigurupati BBA	Executive Director
Dr. Manikandan Ramalingam	Senior Vice President and Head Formulation Research & Development
B. Krishna Mohan	Vice President and Head of IT